Fixed-dose drug combinations which have not received central regulatory approval are sold in substantial numbers in India — despite concerns over the safety and efficacy of these combinations — according to new research.
Fixed-dose drug combinations which have not received central regulatory approval are sold in substantial numbers in India — despite concerns over the safety and efficacy of these combinations — according to new research.